Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,549 INR | +1.08% | +8.58% | -1.10% |
05-14 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
05-10 | Transcript : Dr. Lal PathLabs Limited, Q4 2024 Earnings Call, May 10, 2024 |
Official Publications
No official publication found
- Stock Market
- Equities
- LALPATHLAB Stock
- News Dr. Lal PathLabs Limited
- Official Publications